Makani Science is a medical technology company focused on reinventing respiratory monitoring by developing a wireless, wearable respiratory monitoring system that is accurate, comfortable, and accessible for clinical and home use. Their flagship product is a small, stretchable sensor patch that continuously tracks respiratory rate and breathing waveforms in real time, transmitting data via Bluetooth to mobile devices. This innovation addresses critical needs in patient care, sedation monitoring, sleep apnea, pediatrics, and wellness/performance measurement by enabling earlier detection of respiratory issues and improving patient outcomes[1][2][3].
Founded in 2018 by Dr. Michelle Khine, a biomedical engineering professor and serial entrepreneur, and Dr. Michael Chu, a biomedical engineer with expertise in soft wearable sensors, Makani Science emerged from over a decade of research at the University of California, Irvine. The founders developed the technology in Khine’s lab, supported by grants that helped transition the sensor from concept to a market-ready product. Early pivotal moments include securing FDA 510(k) clearance in 2025, validating the device’s safety and accuracy, and initiating clinical deployments and research collaborations[1][3][7][8].
Core Differentiators
- Product Innovation: The world’s first wireless, stretchable, postage-sized patch that continuously monitors respiratory rate, tidal volume, and minute ventilation in real time.
- Comfort and Usability: Soft, non-invasive sensor design that is comfortable for patients to wear continuously, including ambulatory individuals.
- Real-Time Data Access: Bluetooth connectivity enables immediate respiratory data streaming to smartphones and tablets, allowing healthcare providers and patients to monitor breathing continuously without lag.
- Versatility: Applicable across diverse settings—hospitals, outpatient clinics, athletic performance, and home wellness.
- Advanced Analytics: Plans to integrate machine learning to analyze respiratory waveforms for early prediction of complications.
- Regulatory Validation: FDA 510(k) clearance confirms device safety and clinical reliability[1][2][3][5][8].
Role in the Broader Tech Landscape
Makani Science rides the growing trend of wearable health technology and continuous remote patient monitoring, driven by increasing demand for non-invasive, real-time vital sign tracking outside traditional clinical environments. The timing is critical as healthcare shifts toward proactive, data-driven care models emphasizing early detection and prevention. Market forces such as rising respiratory diseases, aging populations, and the need for safer sedation monitoring favor adoption. By enabling continuous respiratory monitoring with unprecedented comfort and accuracy, Makani Science influences the broader ecosystem by setting new standards for respiratory care and expanding applications into wellness and performance sectors[1][2][8].
Quick Take & Future Outlook
Makani Science is poised to expand its impact by scaling manufacturing, broadening clinical deployments, and enhancing its product with features like heart rate monitoring and longer battery life. Future trends shaping its journey include the integration of AI for predictive respiratory health analytics and growing demand for ambulatory monitoring in diverse populations. As the company matures, it may become a standard of care for respiratory monitoring, reducing hospitalizations and improving quality of life globally. Its innovation not only advances medical device technology but also exemplifies how wearable sensors can transform vital sign monitoring across healthcare and wellness[2][8].
In summary, Makani Science is transforming respiratory monitoring through cutting-edge wearable technology, backed by strong academic roots, regulatory validation, and a clear vision to improve breathing health worldwide.
